SLP halted on Oct 5 2026 at $18.50
SLP0.0%on Mon Oct 5 2026
Simulations Plus, Inc. was up 0.0% on the day at $18.50, ranked #543 on — its usual five-minute volume, when TapeRank recorded this trading halt at 19:50 ET during after hours when it was halted.
THE DAY ON THE LIST · 1 EVENT
- 19:50 ETHALT · AFTER-HOURS
HALTED AT $18.50 · · 0.0% ON THE DAY · — 5M RVOL · RANK #543
No verdict was committed for this event.
THE ROW AND SESSION LEVELS AT 19:50 ET
LAST18.50DAY· 0.0%5 MIN· 0.00%5M RVOL—5M $VOL—FLOAT*20.2MRANK#543SESSIONAFTER-HOURSVWAP18.49HOD18.50LOD18.49OR HIGH18.50OR LOW18.50PREV CLOSE18.50PM HIGH18.49PM LOW18.49GAP· 0.00%* FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE
NO VERDICT MEANS THE MODEL HAD NOT REACHED THE NAME BEFORE THE EVENT WAS FINALIZED, OR ITS ANSWER HEDGED AND WAS WITHHELD. NOTHING WAS FILLED IN AFTERWARDS.
THE SESSION
- 09:30 ETOpened at $18.50, 0.0% on the previous close of $18.50
- 09:30 ETRegular-session high, $18.50
- 10:00 ETRegular-session low, $18.49
- 15:59 ETLast trade of the regular session, $18.50, 0.0% on the previous close of $18.50
- 19:50 ETHalted after the close (T12); no resumption recorded when this note was written
- Volume: 366K shares in regular hours, 100 before the open
SLP opened the regular session at $18.50, matching its previous close, and briefly held that level before dipping to $18.49 at 10:00 ET. It returned to $18.50 by the final regular-session trade at 15:59 ET, finishing unchanged on 366K shares; TapeRank found no filing or news in the prior 24 hours to explain the limited move. A T12 halt was recorded after the close at 19:50 ET at $18.50, with no resumption recorded.
WRITTEN THU OCT 15 2026 18:46 ET BY OPENAI/GPT-5.6-LUNA FROM THE FACTS ON THIS PAGE
FILINGS AND NEWS · 24H BEFORE THE MOVE
No SEC filings or wire news in the 24 hours before this was recorded. A move on news that never reached the wire shows nothing here, which is what UNEXPLAINED means.
On the tape right now
WHERE THE LIST STOODWED NOV 4 2026 · 13:49 ETRECORDED LIVE · 742 QUALIFY
Open the full list